“…Loss-of-function of PDIs can thus result in severe diseases, such as neurodegeneration and diabetes. Notably, redox active site dysfunction in PDIA1 and PDIA6 CxxC motifs induced by posttranslational chemical modifications has been observed in AD 6 , suggesting that misfolding-related pathologies can be ameliorated using redox chemistry 7 . Extracellular PDIs are promising targets for thrombosis-related and tumor diseases owing to the upregulation of PDIs expression level, and several PDIs inhibitors, such as 16F16, bisphenol A, PACMA31, LOC14, and piericone, have been reported [8][9][10][11][12] .…”